Literature DB >> 2992461

In vivo metabolism of leukotriene C4 in man: urinary excretion of leukotriene E4.

L Orning, L Kaijser, S Hammarström.   

Abstract

Five - 20 nmoles of [5,6,8,9,11,12,14,15-3H8]leukotriene C4 was injected into three male volunteers. Forty-eight percent of the administered 3H was recovered from urine and 8% from feces, within a 72 hr period. Of the total urinary radioactivity 44% was excreted during the first hour after injection. This activity was mainly found in one compound, designated "I". The radioactivity excreted into urine later than one hour after injection, consisted partly of Compound I and two additional components, and partly of polar, non-volatile material. Compound I was identified as leukotriene E4 by UV-spectroscopy and cochromatographies in three high performance liquid chromatography systems with synthetic reference compounds. A total of 13% of administered radioactivity was excreted in urine as leukotriene E4.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992461     DOI: 10.1016/0006-291x(85)90404-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.

Authors:  M N Samhoun; D M Conroy; P J Piper
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 3.  Leukotriene receptor antagonists: clinical effects.

Authors:  N Barnes
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

Review 4.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

5.  High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis.

Authors:  Ashlee N King; Jonathan K Fleming; Stephanie S Knapik; Barbara Visentin; Jonathan M Wojciak; Tom Huxford
Journal:  J Lipid Res       Date:  2017-05-15       Impact factor: 5.922

Review 6.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

Review 7.  Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.

Authors:  I K Taylor
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

8.  Endogenous leukotriene D4 formation during anaphylactic shock in the guinea pig.

Authors:  A Keppler; L Orning; K Bernström; S Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99.

Authors:  Lora G Bankova; Juying Lai; Eri Yoshimoto; Joshua A Boyce; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

10.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.